Boston Scientific Corp. closed 12.60% below its 52-week high of $107.17, which the company achieved on February 5th.

Boston Scientific (BSX) closed the latest trading day at $93.67, indicating a +1.11% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 1.81%. At ...

Shares of Boston Scientific Corp. BSX shed 4.27% to $92.64 Thursday, on what proved to be an all-around dismal trading ...

Truist lowered the firm’s price target on Boston Scientific (BSX) to $113 from $120 and keeps a Buy rating on the shares as part of a broad ...

Valued at a market cap of $134.1 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets medical ...

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Boston Scientific (BSX – Research Report).

Boston Scientific plans to break ground soon on a major expansion in Maple Grove, a project that’s up for $1.66 million in ...

Boston Scientific (NYSE: BSX) announced on social media that it completed its previously announced acquisition of Bolt ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging ...

Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...

Boston Scientific (BSX) closed the latest trading day at $102.67, indicating a +1.97% change from the previous session's end. The stock outpaced the S&P 500's daily gain of 1.77%. On the other ...

A diversified portfolio, strategic acquisitions, and aggressive R&D have driven Boston Scientific's recent revenue and EPS growth, outpacing peers like Abbott and Medtronic. Consequently ...